a Phase I Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
Conditions: B Cell Lymphoma; Non Hodgkin Lymphoma Interventions: Biological: MC-1-50 Sponsors: Chongqing Precision Biotech Co., Ltd; Peking University Cancer Hospital& Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer | Cancer & Oncology | Hospitals | Lymphoma | Non-Hodgkin's Lymphoma | Research